Year of Publication
Doctor of Nursing Practice
Sharon Lock, PhD, APRN
Paula Gisler, MSN, RN
Mollie Aleshire, DNP, APRN
Purpose: The primary objective for this retrospective chart review was to evaluate provider adherence to the 2011 AHA/ASA Primary Stroke Prevention guideline of prescribing a statin to all diabetic patients for primary prevention of stroke, regardless of dyslipidemia. A second aim of this study is to identify provider facilitators and barriers to prescribing a statin therapy for primary prevention.
Methods: Using a retrospective study design, a random sample of 100 medical records of diabetic patients presenting to a university women’s health clinic within the previous year were reviewed for statin use and rationale.
Results: Of the 100 diabetic patients sampled, only 69% were currently prescribed a statin therapy. Furthermore, only one patient had a diabetic rationale for statin use. Primary stroke prevention counseling and therapy aimed at prevention of primary stroke will be completed at a future date.
Conclusion: In this clinic setting there is no documentation of adherence to the 2011 AHA/ASA Primary Stroke Prevention Guideline recommendation that statin therapy be used as a primary prevention in the diabetic population.
Hatcher, Amy L., "Primary Stroke Prevention: 3-hydroxy-3-methyl-glutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitor (statin) Use in the Diabetic Patient" (2014). DNP Projects. 22.